Drug delivery and targeting.
R Langer - Nature, 1998 - europepmc.org
When a pharmaceutical agent is encapsulated within, or attached to, a polymer or lipid, drug
safety and efficacy can be greatly improved and new therapies are possible. This has …
safety and efficacy can be greatly improved and new therapies are possible. This has …
Current status and future potential of transdermal drug delivery
The past twenty five years have seen an explosion in the creation and discovery of new
medicinal agents. Related innovations in drug delivery systems have not only enabled the …
medicinal agents. Related innovations in drug delivery systems have not only enabled the …
[HTML][HTML] Guidelines: Editor's choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European …
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …
for personal and educational use only. No commercial use is authorized. No part of the ESC …
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics
NL Benowitz - Annual review of pharmacology and toxicology, 2009 - annualreviews.org
Nicotine sustains tobacco addiction, a major cause of disability and premature death.
Nicotine binds to nicotinic cholinergic receptors, facilitating neurotransmitter release and …
Nicotine binds to nicotinic cholinergic receptors, facilitating neurotransmitter release and …
[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice
MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …
Biomaterials in drug delivery and tissue engineering: one laboratory's experience
R Langer - Accounts of Chemical Research, 2000 - ACS Publications
This Account reviews our laboratory's research in biomaterials. In one area, drug delivery,
we discuss the development of materials that are capable of releasing macromolecules such …
we discuss the development of materials that are capable of releasing macromolecules such …
US public health service clinical practice guideline: treating tobacco use and dependence.
MC Fiore - Respiratory care, 2000 - europepmc.org
Treating Tobacco Use and Dependence, a Public Health Service-sponsored Clinical
Practice Guideline, is a product of the Tobacco Use and Dependence Guideline Panel (" the …
Practice Guideline, is a product of the Tobacco Use and Dependence Guideline Panel (" the …
[HTML][HTML] Nicotine replacement therapy: an overview
U Wadgave, L Nagesh - International journal of health sciences, 2016 - ncbi.nlm.nih.gov
Today tobacco use is the single greatest preventable cause of death in the world. Tobacco
use is often incorrectly perceived to be solely a personal choice. This is contradicted by the …
use is often incorrectly perceived to be solely a personal choice. This is contradicted by the …
Monoamine transporters and psychostimulant drugs
RB Rothman, MH Baumann - European journal of pharmacology, 2003 - Elsevier
Most psychostimulants interact with monoamine transport proteins. This paper reviews work
our laboratory has conducted to investigate the interaction of psychostimulants with …
our laboratory has conducted to investigate the interaction of psychostimulants with …
Neurobiology of nicotine addiction: implications for smoking cessation treatment
NL Benowitz - The American journal of medicine, 2008 - Elsevier
Nicotine sustains addictive tobacco use, which in turn causes much premature disability and
death. The essence of drug addiction is loss of control of drug use. Molecular biology studies …
death. The essence of drug addiction is loss of control of drug use. Molecular biology studies …